• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入性糖皮质激素治疗的哮喘患者肺功能昼夜节律的定量特征

Quantitative characterization of circadian rhythm of pulmonary function in asthmatic patients treated with inhaled corticosteroids.

作者信息

Zhou Di, Li Hongshan, Wang Yaning, Hochhaus Guenther, Sinha Vikram, Zhao Liang

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Florida, 1600 SW Archer Road, Gainesville, FL, USA.

出版信息

J Pharmacokinet Pharmacodyn. 2015 Aug;42(4):391-9. doi: 10.1007/s10928-015-9420-6. Epub 2015 Jun 23.

DOI:10.1007/s10928-015-9420-6
PMID:26099861
Abstract

The aim of this study was to characterize the circadian rhythm observed for forced expiratory volume in 1 s (FEV1) in patients with persistent asthma being treated with inhaled corticosteroids. The database included 3379 FEV1 measurements from 189 patients with mild to moderate asthma. A model using the sum of two Sine functions with periods of 12 and 24 h and a constant component of mean circadian rhythm adequately described the circadian rhythm in FEV1 measurements over time. The model adequateness was evaluated by various approaches including visual predictive check (VPC), prediction-corrected VPC, standardized VPC and normalized prediction distribution error. Covariates tested included age, body weight, height, body mass index, baseline FEV1, and sex. Age and height were found to have significant effects on the mean FEV1 level and no covariate was found to have an effect on the magnitude and timing of circadian rhythm. The model predicted that a minimum FEV1 occurred in the early morning and maximum FEV1 occurred in the early afternoon, with a population mean fluctuation of 170 mL, which is consistent with the finding that asthma symptoms usually exacerbate in the early morning for patients with persistent asthma. This developed model provides the first quantitative approach to describing FEV1 circadian rhythm with ICS background treatment and provided insight in designing future registration trials for asthma drug development.

摘要

本研究的目的是描述接受吸入性糖皮质激素治疗的持续性哮喘患者1秒用力呼气量(FEV1)的昼夜节律特征。数据库包含了189例轻至中度哮喘患者的3379次FEV1测量值。一个使用周期为12小时和24小时的两个正弦函数之和以及平均昼夜节律恒定成分的模型充分描述了FEV1测量值随时间的昼夜节律。通过多种方法评估模型的适用性,包括视觉预测检查(VPC)、预测校正VPC、标准化VPC和归一化预测分布误差。测试的协变量包括年龄、体重、身高、体重指数、基线FEV1和性别。发现年龄和身高对平均FEV1水平有显著影响,未发现协变量对昼夜节律的幅度和时间有影响。该模型预测,FEV1最低值出现在清晨,最高值出现在下午早些时候,总体平均波动为170 mL,这与持续性哮喘患者哮喘症状通常在清晨加重的发现一致。这个开发的模型提供了第一种在ICS背景治疗下描述FEV1昼夜节律的定量方法,并为设计未来哮喘药物开发的注册试验提供了见解。

相似文献

1
Quantitative characterization of circadian rhythm of pulmonary function in asthmatic patients treated with inhaled corticosteroids.吸入性糖皮质激素治疗的哮喘患者肺功能昼夜节律的定量特征
J Pharmacokinet Pharmacodyn. 2015 Aug;42(4):391-9. doi: 10.1007/s10928-015-9420-6. Epub 2015 Jun 23.
2
A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.一项为期12周的多中心、随机、部分盲法、活性药物对照、平行组研究,旨在评估布地奈德吸入混悬液用于此前使用定量气雾剂或干粉吸入器吸入皮质类固醇治疗的中度至重度持续性哮喘青少年和成人患者的疗效。
Clin Ther. 2007 Jun;29(6):1013-26. doi: 10.1016/j.clinthera.2007.06.005.
3
Chronobiology and asthma. III. Timing corticotherapy to biological rhythms to optimize treatment goals.
J Asthma. 1988;25(4):219-48. doi: 10.3109/02770908809071368.
4
The acute effects of bronchial thermoplasty on FEV.支气管热成形术对 FEV 的急性影响。
Respir Med. 2018 Apr;137:147-151. doi: 10.1016/j.rmed.2018.03.003. Epub 2018 Mar 3.
5
The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.在中度/持续性哮喘中,吸入长效β2肾上腺素能激动剂(LABA)和皮质类固醇(ICS)的治疗效果不受其吸入顺序的影响。
Eur Ann Allergy Clin Immunol. 2006 May;38(5):153-7.
6
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).孟鲁司特或沙美特罗联合吸入性糖皮质激素治疗成人哮喘:一项随机、双盲对照研究的设计与原理(孟鲁司特作为辅助治疗药物的IMPACT研究)
Respir Med. 2000 Jun;94(6):612-21. doi: 10.1053/rmed.2000.0806.
7
[The role of lung volume measurements by plethysmography in the follow-up of asthma in children].[体积描记法测量肺容积在儿童哮喘随访中的作用]
Rev Mal Respir. 2010;27(1):42-8. doi: 10.1016/j.rmr.2009.11.002. Epub 2009 Dec 1.
8
Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?哮喘和慢性阻塞性肺疾病急性加重期肺功能下降——能否在不进行肺量计检查的情况下进行评估?
Int J Chron Obstruct Pulmon Dis. 2016 Dec 8;11:3145-3152. doi: 10.2147/COPD.S123315. eCollection 2016.
9
Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.与痰液分析、血清白细胞介素和肺功能相比,呼出一氧化氮用于监测儿童哮喘炎症。
Pediatr Pulmonol. 2008 Feb;43(2):134-41. doi: 10.1002/ppul.20747.
10
Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.每日一次的噻托溴铵Respimat(®)5微克对有症状的成年哮喘患者是一种有效的24小时支气管扩张剂。
Respir Med. 2015 Mar;109(3):329-38. doi: 10.1016/j.rmed.2014.12.005. Epub 2014 Dec 27.

引用本文的文献

1
Recent Advances in Chronotherapy Targeting Respiratory Diseases.针对呼吸系统疾病的时间治疗学最新进展
Pharmaceutics. 2021 Nov 25;13(12):2008. doi: 10.3390/pharmaceutics13122008.
2
Asthma diagnosis: into the fourth dimension.哮喘诊断:进入第四维度。
Thorax. 2021 Jun;76(6):624-631. doi: 10.1136/thoraxjnl-2020-216421. Epub 2021 Jan 27.

本文引用的文献

1
Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo response.哮喘患者纵向第一秒用力呼气容积(FEV1)数据的人群模型:荟萃分析及安慰剂反应的可预测性
J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):553-69. doi: 10.1007/s10928-014-9373-1. Epub 2014 Aug 15.
2
The circadian clock and asthma.昼夜节律钟与哮喘。
Thorax. 2014 Jan;69(1):90-2. doi: 10.1136/thoraxjnl-2013-203482. Epub 2013 May 23.
3
Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease.
在慢性阻塞性肺疾病患者中,吸入性 PF-00610355 和沙美特罗的纵向 FEV1 剂量反应模型。
J Pharmacokinet Pharmacodyn. 2012 Dec;39(6):619-34. doi: 10.1007/s10928-012-9274-0. Epub 2012 Sep 23.
4
Smoking and asthma.吸烟与哮喘。
J Am Board Fam Med. 2011 May-Jun;24(3):313-22. doi: 10.3122/jabfm.2011.03.100180.
5
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.用于诊断非线性混合效应模型的预测校正可视化预测检验。
AAPS J. 2011 Jun;13(2):143-51. doi: 10.1208/s12248-011-9255-z. Epub 2011 Feb 8.
6
Standardized visual predictive check versus visual predictive check for model evaluation.标准化视觉预测检查与模型评估的视觉预测检查。
J Clin Pharmacol. 2012 Jan;52(1):39-54. doi: 10.1177/0091270010390040. Epub 2011 Jan 21.
7
Population pharmacodynamic model of the longitudinal FEV1 response to an inhaled long-acting anti-muscarinic in COPD patients.COPD 患者吸入长效抗毒蕈碱药物后 FEV1 的纵向反应的群体药代动力学模型。
J Pharmacokinet Pharmacodyn. 2011 Feb;38(1):105-19. doi: 10.1007/s10928-010-9180-2. Epub 2010 Nov 20.
8
Piraña and PCluster: a modeling environment and cluster infrastructure for NONMEM.Piraña 和 PCluster:NONMEM 的建模环境和集群基础设施。
Comput Methods Programs Biomed. 2011 Jan;101(1):72-9. doi: 10.1016/j.cmpb.2010.04.018. Epub 2010 Jun 2.
9
The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta-analysis.福莫特罗在使用吸入性糖皮质激素的哮喘患者中的安全性。系统评价与荟萃分析。
Pol Arch Med Wewn. 2008 Nov;118(11):627-35.
10
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.计算归一化预测分布误差以评估非线性混合效应模型:用于R的npde附加包。
Comput Methods Programs Biomed. 2008 May;90(2):154-66. doi: 10.1016/j.cmpb.2007.12.002. Epub 2008 Jan 22.